The project on the development of new sensitive biomarks for early diagnosis and a better classification of neuroendocrine tumours is well established and running accord to plan. The first patients with NETs have been included in a unique clinical trial with an Oncolytic virus that is only killing the tumour cells and respect normal cells. The results so far look very promising. We expect to get specimens from 35 patients.
Collaboration with Mi Fundación Alex
In 2024, Invest for children made a contribution to Mi Fundación Alex to support the creation of an adaptive sailing school. This school will provide individuals with disabilities the opportunity…
see project 
